Study to investigate the safety and efficacy of tacrolimus in kidney transplant recipients
- Registry ID
- EUCTR2015-003288-12
- Source registry
- EUCTR
- Phase
- PHASE3
- Sponsor
- Fujisawa Healthcare, Inc.
- Last update
- 2026-08-16
Conditions
- Kidney transplant recipients
Summary
To compare the safety and efficacy ofPrograf®/MMF and
Neoral®/MMF in de novo kidney transplant recipients.
To compare the safety and efficacy of Modified Release (MR)
Tacrolimus/MMF and Neoral®/MMF in de novo kidney transplant
recipients.
View on source registry